Ayrton Drug Manufacturing Ltd. announced earnings results for the full year ended June 30, 2019. For the full year, the company announced sales was GHS 27.136 million compared to GHS 36.218 million a year ago. Operating loss was GHS 1.168 million compared to operating Income of GHS 7.152 million a year ago. Net loss was GHS 2.464 million compared to net income of GHS 3.615 million a year ago. Basic loss per share was GHS 0.0115 compared to basic earnings per share of GHS 0.0168 a year ago.